Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-11 |
mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-11 |
mRNA | GPR35 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-11 |
mRNA | THAP9 | CTRPv2 | pan-cancer | AAC | -0.25 | 5e-11 |
mRNA | SENP1 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-11 |
mRNA | SFXN3 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-11 |
mRNA | PTPRE | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
mRNA | ARAP3 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | LPCAT2 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | CCP110 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-10 |